These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 36127526)
1. Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric Cancer. Sawaki K; Kanda M; Baba H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Kodera Y Ann Surg Oncol; 2023 Jan; 30(1):628-636. PubMed ID: 36127526 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis. Sasahara M; Kanda M; Tanaka C; Shimizu D; Umeda S; Takami H; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y Int J Cancer; 2024 Apr; 154(7):1272-1284. PubMed ID: 38151776 [TBL] [Abstract][Full Text] [Related]
3. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565 [TBL] [Abstract][Full Text] [Related]
4. Gamma-Aminobutyric Acid Type A Receptor Subunit Delta ( Wu L; Zhang Y; Zheng C; Zhao F; Lin Y Iran J Public Health; 2023 Mar; 52(3):542-552. PubMed ID: 37124892 [TBL] [Abstract][Full Text] [Related]
5. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895 [TBL] [Abstract][Full Text] [Related]
6. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of human kallikrein 12 gene expression in gastric cancer. Zhao EH; Shen ZY; Liu H; Jin X; Cao H World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234 [TBL] [Abstract][Full Text] [Related]
8. The role of TRPV1 ion channels in the suppression of gastric cancer development. Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449 [TBL] [Abstract][Full Text] [Related]
9. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer. Song J; Liu Y; Wang T; Li B; Zhang S Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210 [TBL] [Abstract][Full Text] [Related]
10. Research for Expression and Prognostic Value of GABRD in Colon Cancer and Coexpressed Gene Network Construction Based on Data Mining. Liu T; Fang Y Comput Math Methods Med; 2021; 2021():5544182. PubMed ID: 34194536 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7. Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer. Ge F; Wang C; Wang W; Liu W; Wu B Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of long non-coding RNA DQ786243 promotes the progression of gastric cancer. Shan T; Fan J; Zhao Q; Deng K; Xia J Mol Med Rep; 2017 Oct; 16(4):3761-3768. PubMed ID: 28731138 [TBL] [Abstract][Full Text] [Related]
14. GABRD promotes progression and predicts poor prognosis in colorectal cancer. Niu G; Deng L; Zhang X; Hu Z; Han S; Xu K; Hong R; Meng H; Ke C Open Med (Wars); 2020; 15(1):1172-1183. PubMed ID: 33336074 [TBL] [Abstract][Full Text] [Related]
15. Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins. Yuan L; Li JX; Yang Y; Chen Y; Ma TT; Liang S; Bu Y; Yu L; Nan Y World J Gastroenterol; 2021 Apr; 27(16):1785-1804. PubMed ID: 33967557 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation. Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097 [TBL] [Abstract][Full Text] [Related]
17. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4. Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402 [TBL] [Abstract][Full Text] [Related]
18. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5. Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189 [TBL] [Abstract][Full Text] [Related]
19. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target. Mao ZB; Zhang JF; Xu Z; Zhu HJ; Zhang JG; Pan ZP; Xiao F; Yang JL J Dig Dis; 2009 Nov; 10(4):272-85. PubMed ID: 19906106 [TBL] [Abstract][Full Text] [Related]
20. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]